Motor functioning during and following treatment with chemotherapy for pediatric acute lymphoblastic leukemia

Pediatric Blood and Cancer

Volumn 60, Issue 8, 2013, Pages 1261-1266

  Green, Jessica L ^a,b   Knight, Sarah J ^b   Mccarthy, Maria ^a,b   De Luca, Cinzia R ^a,b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

Acute lymphoblastic leukemia; Child; Motor skills; Neoplasms

Indexed keywords

METHOTREXATE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RISK; CANCER SURVIVOR; CHILDHOOD LEUKEMIA; EMPIRICISM; HUMAN; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; VISUOMOTOR COORDINATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MOTOR SKILLS; MOTOR SKILLS DISORDERS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK FACTORS; TIME FACTORS;

EID: 84879200530     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24537     Document Type: Review

References (58)

1. Hunger SP, Lu X, Devidas M, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: A report from the Children's Oncology Group. J Clin Oncol 2012; 30:1663-1669.
2. Howlader N, Noone AM, Krapcho M, et al. 2009 08/6/2012. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). National Cancer Institute. Available from: http://seer.cancer.gov/csr/1975_2009_pops09/ (Accessed 6 August 2012).
3. Montgomery M, Huang S, Cox CL, et al. Physical therapy and chiropractic use among childhood cancer survivors with chronic disease: Impact on health-related quality of life. J Cancer Surviv 2011; 5:73-81.
4. Mody R, Li S, Dover DC, et al. Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study. Blood 2008; 111:5515-5523.
5. Ness KK, Gurney JG. Adverse late effects of childhood cancer and its treatment on health and performance. Annu Rev Public Health 2007; 28:279-302.
6. Brown RT, Madan-Swain A, Walco GA, et al. Cognitive and academic late effects among children previously treated for acute lymphocytic leukemia receiving chemotherapy as CNS prophylaxis. J Pediatr Psychol 1998; 23:333-340.
7. Vainionpaa L, Kovala T, Tolonen U, et al. Chemotherapy for acute lymphoblastic leukemia may cause subtle changes of the spinal cord detectable by somatosensory evoked potentials. Med Pediatr Oncol 1997; 28:41-47.
8. Wright MJ, Halton JM, Martin RF, et al. Long-term gross motor performance following treatment for acute lymphoblastic leukemia. Med Pediatr Oncol 1998; 31:86-90.
9. Ramchandren S, Leonard M, Mody RJ, et al. Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia. J Peripher Nerv Syst 2009; 14:184-189.
10. Gilchrist L, Tanner L, Hooke M. Measuring chemotherapy-induced peripheral neuropathy in children 5-18: A pilot study. Rehabil Oncol 2009; 27:24.
11. Diaz-Jaimes E, Penaloza-Ochoa L, Onoko PMP. Electrophysiological changes of peripheral neuropathy with vincristine after a physical therapy program in pediatric patients with acute lymphoblastic leukemia. Bol Med Hosp Infant Mex 2009; 66.
12. Harila-Saari AH, Huuskonen UE, Tolonen U, et al. Motor nervous pathway function is impaired after treatment of childhood acute lymphoblastic leukemia: A study with motor evoked potentials. Med Pediatr Oncol 2001; 36:345-351.
13. Davis EE, Pitchford NJ, Limback E. The interrelation between cognitive and motor development in typically developing children aged 4-11 years is underpinned by visual processing and fine manual control. Br J Psychol (Lond) 2011; 102:569-584.
14. Sortor J, Kulp M. Are the results of the Beery-Buktenica developmental test of visual-motor integration and its subtests related to achievement test scores? Optom Vis Sci 2003; 80:758-763.
15. Libertus K, Needham A. Reaching experience increases face preference in 3-month-old infants. Dev Sci 2011; 14:1355-1364. doi: 1310.1111/j.1467-7687.2011.01084.x. Epub. 2011 Sep. 01089.
16. Cummins A, Piek JP, Dyck MJ. Motor coordination, empathy, and social behaviour in school-aged children. Dev Med Child Neurol 2005; 47:437-442.
17. Lackner H, Benesch M, Schagerl S, et al. Prospective evaluation of late effects after childhood cancer therapy with a follow-up over 9 years. Eur J Pediatr 2000; 159:750-758.
18. Moleski M. Neuropsychological neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Arch Clin Neuropsychol 2000; 15:603-630.
19. Janzen LA, Spiegler BJ. Neurodevelopmental sequelae of pediatric acute lymphoblastic leukemia and its treatment. Dev Disabil Res Rev 2008; 14:185-195.
20. Peterson CC, Johnson CE, Ramirez LY, et al. A meta-analysis of the neuropsychological sequelae of chemotherapy-only treatment for pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer 2008; 51:99-104.
21. Winter C, Muller C, Hoffmann C, et al. Physical activity and childhood cancer. Pediatr Blood Cancer 2010; 54:501-510.
22. Ness KK, Hudson MM, Ginsberg JP, et al. Physical performance limitations in the Childhood Cancer Survivor Study cohort. J Clin Oncol 2009; 27:2382-2389.
23. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 2009; 6:e1000097.
24. Wakefield CE, McLoone JK, Butow P, et al. Parental adjustment to the completion of their child's cancer treatment. Pediatr Blood Cancer 2011; 56:524-531.
25. Dowell RE, Copeland DR, Judd BW. Neuropsychological effects of chemotherapeutic agents. Dev Neuropsychol 1989; 5:17-24.
26. Reinders-Messelink H, Schoemaker M, Snijders T, et al. Motor performance of children during treatment for acute lymphoblastic leukemia. Med Pediatr Oncol 1999; 33:545-550.
27. Hartman A, te Winkel ML, van Beek RD, et al. A randomized trial investigating an exercise program to prevent reduction of bone mineral density and impairment of motor performance during treatment for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2009; 53:64-71.
28. Van Brussel M, Takken T, Van Der Net J, et al. Physical function and fitness in long-term survivors of childhood leukaemia. Pediatr Rehabil 2006; 9:267-274.
29. Hartman A, van den Bos C, Stijnen T, et al. Decrease in motor performance in children with cancer is independent of the cumulative dose of vincristine. Cancer 2006; 106:1395-1401.
30. Hartman A, van den Bos C, Stijnen T, et al. Decrease in peripheral muscle strength and ankle dorsiflexion as long-term side effects of treatment for childhood cancer. Pediatr Blood Cancer 2008; 50:833-837.
31. Henderson S, Sugden D. Movement assessment battery for children. Kent: Psychological Corporation; 1992.
32. Hartman A, Pieters R, van den Bos C, et al. Perceived and actual motor competence of children treated for cancer with vincristine containing chemotherapy. Pediatr Blood Cancer 2008; 51:306-307.
33. Bruininks R. Bruininks-Oseretsky test of motor proficiency, 2nd edition. Minneapolis: AGS Publishing; 2005.
34. Marchese VG, Chiarello LA, Lange BJ. Effects of physical therapy intervention for children with acute lymphoblastic leukemia. Pediatr Blood Cancer 2004; 42:127-133.
35. Ness KK, Baker KS, Dengel DR, et al. Body composition, muscle strength deficits and mobility limitations in adult survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2007; 49:975-981.
36. National Health and Medical Research Council (NHMRC). How to use the evidence: Assessment and application of scientific evidence. Canberra; 2000. Report.
37. Tiffin J. Purdue pegboard: Examiner manual. Chicago: Science Research Associates; 1968.
38. Lezak M. Neuropsychological assessment. New York: Oxford University Press; 1983.
39. Hamstra-Bletz L, Blöte AW. A longitudinal study on dysgraphic handwriting in primary school. J Learn Disabil 1993; 26:689-699.
40. Kaemingk KL, Carey ME, Moore IM, et al. Math weaknesses in survivors of acute lymphoblastic leukemia compared to healthy children. Child Neuropsychol 2004; 10:14-23.
41. Hartman A, van den Bos C, van Dartel N, et al. No adverse effect of vincristine on handwriting in children after completion of therapy. Pediatr Blood Cancer 2007; 49:841-845.
42. Hartman A, van Schaik RHN, van der Heiden IP, et al. Polymorphisms in genes involved in vincristine pharmacokinetics or pharmacodynamics are not related to impaired motor performance in children with leukemia. Leuk Res 2010; 34:154-159.
43. Reinders-Messelink HA, Schoemaker MM, Hofte M, et al. Fine motor and handwriting problems after treatment for childhood acute lymphoblastic leukemia. Med Pediatr Oncol 1996; 27:551-555.
44. Reinders-Messelink HA, Schoemaker MM, Snijders TA, et al. Analysis of handwriting of children during treatment for acute lymphoblastic leukemia. Med Pediatr Oncol 2001; 37:393-399.
45. Copeland DR, Dowell RE, Fletcher JM, et al. Neuropsychological test performance of pediatric cancer patients at diagnosis and one year later. J Pediatr Psychol 1988; 13:183-196.
46. Jansen NC, Kingma A, Tellegen P, et al. Feasibility of neuropsychological assessment in leukaemia patients shortly after diagnosis: Directions for future prospective research. Arch Dis Child 2005; 90:301-304.
47. Kingma A, van Dommelen RI, Mooyaart EL, et al. Slight cognitive impairment and magnetic resonance imaging abnormalities but normal school levels in children treated for acute lymphoblastic leukemia with chemotherapy only. J Pediatr 2001; 139:413-420.
48. Hockenberry M, Krull K, Moore K, et al. Longitudinal evaluation of fine motor skills in children with leukemia. J Pediatr Hematol Oncol 2007; 29:535-539.
49. Jansen NCAJ, Kingma A, Schuitema A, et al. Neuropsychological outcome in chemotherapy-only-treated children with acute lymphoblastic leukemia. J Clin Oncol 2008; 26:3025-3030.
50. Copeland DR, Moore BD, Francis DJ, et al. Neuropsychologic effects of chemotherapy on children with cancer: A longitudinal study. J Clin Oncol 1996; 14:2826-2835.
51. Beery K. Developmental test of visual-motor integration: Administration and scoring manual. Chicago: Follett Pub; 1967.
52. Brown RT, Madan-Swain A, Pais R, et al. Chemotherapy for acute lymphocytic leukemia: Cognitive and academic sequelae. J Pediatr 1992; 121:885-889.
53. Espy KA, Moore IM, Kaufmann PM, et al. Chemotherapeutic CNS prophylaxis and neuropsychologic change in children with acute lymphoblastic leukemia: A prospective study. J Pediatr Psychol 2001; 26:1-9.
54. Krappmann P, Paulides M, Stohr W, et al. Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: Results of an Austrian-German multicenter longitudinal study and implications for follow-up. Pediatr Hematol Oncol 2007; 24:101-109.
55. Buizer AI, De Sonneville LMJ, Van Den Heuvel-Eibrink MM, et al. Visuomotor control in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only. J Int Neuropsychol Soc 2005; 11:554-565.
56. Kadan-Lottick NS, Brouwers P, Breiger D, et al. Comparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatment of childhood acute lymphoblastic leukemia. J Clin Oncol 2009; 27:5986-5992.
57. Carey ME, Hockenberry MJ, Moore IM, et al. Brief report: Effect of intravenous methotrexate dose and infusion rate on neuropsychological function one year after diagnosis of acute lymphoblastic leukemia. J Pediatr Psychol 2007; 32:189-193.
58. Jackson C, Cheater FM, Reid I. A systematic review of decision support needs of parents making child health decisions. Health Expectations 2008; 11:232-251.